An experimental Alzheimer's drug shows promise targeting a different brain protein, new st

An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows. An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments—by lowering levels of a brain protein called tau, researchers reported Tuesday.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments—by lowering levels of a brain protein called tau, researchers reported Tuesday.

• Ponto de atenção: experimental.
• Ponto de atenção: alzheimer.
• Ponto de atenção: drug.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.